Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
UHAL Amerco
BAC Bank of America Corp
BA Boeing Co
EGRNF China Evergrande Group
SHYF Shyft Group Inc
NGS Natural Gas Services Group Inc
CDMO Avid Bioservices Inc
DCRCU Decarbonization Plus Acquisition Corporation III
RHHBY Roche Holding AG
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.

Closing Price
$43.89
Day's Change
-0.58 (-1.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
44.46
Day's Low
43.31
Volume
(Heavy Day)
Volume:
56,420,686

10-day average volume:
27,296,668
56,420,686

Company Profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.

Valuation Ratios

Price/Earnings (TTM)
20.05x
Price/Sales (TTM)
4.43x
Price/Book (MRQ)
3.51x
Price/Cash Flow (TTM)
14.21x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

August 2021
Current Month
58.7M
Previous Month
61.4M
Percent of Float
1.05%
Days to Cover
1.1677 Days

Share Information

PFE is in a share class of common stock
Float
5.6B
Shares Outstanding
5.6B
Institutions Holding Shares
3,363
64.92%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Albert BourlaChmn.
  • John D. YoungPres.
  • Frank A. D'amelioCFO
  • Angela HwangCorp.Exec.
  • Lidia FonsecaExec.VP

Address

Insider Trading

During the most recent quarter, 7K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.